L2P4

• Description :

  L2P4 is a peptide-based and EBNA1 targeting fluorescent probe, which inhibits the EBNA1 homodimer formation and selectively inhibits EBV+ tumor growth. L2P4 exhibits cytotoxicity in EBV-positive C666-1 cell with LC50 of 46.4 μM[1].

• UNSPSC :

  12352209

• Target :

  EBV; Peptide-Drug Conjugates (PDCs)

• Type :

  Peptides

• Related Pathways :

  Antibody-drug Conjugate/ADC Related; Anti-infection

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/l2p4.html

• Smiles :

  O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CCSC)C(N[C@@H](C(C)C)C(N[C@@H](CC2=CC=CC=C2)C(NCC(NCC(N[C@@H](CCCNC(N)=N)C(N[C@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@@H](NC(CCCCCNC([C@@H](NC(C[N+]3=CC=C(/C=C/C(C=C4)=CC=C4N(CC)CC)C=C3)=O)CS)=O)=O)CC5=CC=C(O)C=C5.[Cl-]

• Molecular Formula :

  C93H138ClN25O16S2

• Molecular Weight :

  1961.83

• References & Citations :

  [1]Li X, et al., Biocompatible Porphyrin-Peptide Conjugates as Theranostic Agents Targeting the Epstein-Barr Virus. Chempluschem. 2022 Aug 10;87 (11) :e202200184.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [2141991-98-0]